Dong-A Socio Holdings Co., Ltd. (000640)
Market Closed
12 Dec, 06:30
KRX SM KRX SM Primary ₩
121,600. 00
-800
-0.65%
₩
737.18B Market Cap
- P/E Ratio
1,400% Div Yield
13,351 Volume
- Eps
₩ 122,400
Previous Close Day Range
120,800 125,500
Year Range
90,582.52 125,500
Want to track 000640 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 57 days
Summary
000640 closed Friday lower at ₩121,600, a decrease of 0.65% from Thursday's close, completing a monthly increase of 0.33% or ₩400. Over the past 12 months, 000640 stock gained 13.86%.
000640 pays dividends to its shareholders, with the most recent payment made on Aug 14, 2025. The next estimated payment will be in 3 months ago on Sep 14, 2025 for a total of ₩700.
The last earnings report, released on Oct 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 09, 2026.
Dong-A Socio Holdings Co., Ltd. has completed 1 stock splits, with the recent split occurring on Apr 08, 2013.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).
Dong-A Socio Holdings Co., Ltd. (000640) FAQ
What is the stock price today?
The current price is ₩121,600.00.
On which exchange is it traded?
Dong-A Socio Holdings Co., Ltd. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 000640.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1,400%.
What is its market cap?
As of today, the market cap is 737.18B.
When is the next earnings date?
The next earnings report will release on Feb 09, 2026.
Has Dong-A Socio Holdings Co., Ltd. ever had a stock split?
Dong-A Socio Holdings Co., Ltd. had 1 splits and the recent split was on Apr 08, 2013.
Dong-A Socio Holdings Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Min-Young Kim CEO | KRX SM Exchange | KR7000640003 ISIN |
| KR Country | 83 Employees | - Last Dividend | 13 Mar 2025 Last Split | - IPO Date |
Overview
Dong-A Socio Holdings Co., Ltd. is a prominent entity in the pharmaceutical domain, both within South Korea and on a global scale. Founded in 1932, the company has its headquarters in Seoul, South Korea. It is reputed for its significant contributions to pharmaceutical research and development, particularly focusing on various therapeutic areas including type 2 diabetes, obesity, overactive bladder, anemia, HIV-1, and cancer, among others. Besides its core pharmaceutical business, Dong-A Socio Holdings extends its expertise into healthcare solutions, CDMO services, production of imaging equipment, mineral water, and also ventures into IT and construction services.
Products and Services
- DA-1241 - A groundbreaking development aimed at treating type 2 diabetes and non-alcoholic steatohepatitis.
- DA-1726 - An oxyntomodulin analogue for obesity treatment, showcasing the company's dedication to addressing metabolic disorders.
- DA-1229 - A dipeptidyl peptidase-4 inhibitor, reflecting the company's innovation in diabetes management.
- DA-8010 - A muscarinic M3 receptor antagonist developed for the treatment of overactive bladder, highlighting the company's focus on improving quality of life.
- DMB-3115 - A biosimilar of Stelara, targeted at inflammatory disease treatment, demonstrating the company's competence in biosimilars.
- DA-3880 - An innovative solution for anemia treatment, underpinning the firm's dedication to comprehensive healthcare.
- STP0404 - An HIV-1 treatment drug, indicative of the company's contribution to infectious disease therapeutics.
- STP1002 - An anti-cancer drug, showcasing the company's commitment to oncology and the development of life-saving medications.
- Healthcare Solutions - Provides an array of healthcare solutions in Bacchus, over-the-counter, consumer healthcare, and derma business areas, reflecting its diverse approach to healthcare.
- CDMO Services - Offers Contract Development and Manufacturing Organization services, underlining its versatility in pharmaceutical manufacturing.
- Imaging Equipment and ENT Workstation Products - Develops medical imaging equipment and ENT workstation products, leveraging its technological capabilities in medical devices.
- Mineral Water - Markets mineral water under the Cheonnyeonsu brand name, expanding its business into consumer goods.
- IT and Construction Services - Engages in IT and construction services, illustrating the company's multi-dimensional business model.
- Glass Bottles, PET, and Corrugated Cardboard Boxes Production - Produces packaging materials, demonstrating its operational diversity and commitment to sustainability.
- Foundry Equipment, Logistics, and Food and Beverage Businesses - Participates in a variety of sectors, highlighting its broad business interests and ability to innovate across industries.
Contact Information
Address: 64, Cheonho-daero, Seoul, South Korea, 02587
Phone: 82 2 920 8114
Website: https://www.donga.co.kr
2025 © Marketlog. All Rights Reserved.
